This is a working overview of Nicotinamide mononucleotide, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-02-11 and is reviewed periodically as new material appears.
NAD+ serves as a coenzyme in redox reactions and as a substrate for enzymes involved in DNA repair and cellular signaling. In the salvage pathway, nicotinamide is converted to NMN by the enzyme NAMPT. NMN is then converted to NAD+ by NMNAT enzymes. A separate route links nicotinamide riboside to NMN through phosphorylation. These pathways maintain NAD+ levels, which can decline with age or metabolic stress in some tissues. The relative contribution of circulating NMN to tissue NAD+ remains an active area of study.
Research on NMN includes cell studies, animal experiments, and a growing number of human trials. Many early findings come from mice, where changes in NAD+ levels and metabolic markers have been reported. Human data are more limited, and questions remain about effective routes of administration, tissue distribution, and long-term effects. Some trials measure NAD+ in blood or tissue, while others assess physical function or metabolic outcomes. Regulatory status differs between countries, and NMN is not universally approved as a dietary supplement or therapeutic agent.
Research interest in NMN increased after animal studies reported that oral or injected NMN can raise NAD+ levels in some tissues. How NMN is absorbed and distributed in humans is not fully established. Some evidence suggests extracellular NMN may be dephosphorylated to nicotinamide riboside before cellular uptake, while other studies propose specific transport routes. Direct human data on these mechanisms remain limited. Regulatory status also varies: in some countries NMN is treated as a dietary supplement, while elsewhere it is restricted or requires approval, and these differences affect labeling, sale, and research.
Nicotinamide mononucleotide, commonly abbreviated NMN, is a naturally occurring nucleotide found in the cells of many organisms. Its structure consists of a nicotinamide group linked to a ribose sugar that carries a phosphate group. NMN is an intermediate in the biosynthesis of nicotinamide adenine dinucleotide, or NAD+, a coenzyme involved in many metabolic reactions. The abbreviation usually refers to the beta anomer, though related forms can exist. In scientific literature, NMN is distinct from nicotinamide riboside, another NAD+ precursor.
In the NAD+ salvage pathway, the enzyme NAMPT converts nicotinamide and a phosphate-donor molecule into NMN. A second enzyme, NMNAT, then converts NMN into NAD+. Nicotinamide riboside can also enter this route after being converted to NMN by nicotinamide riboside kinases. Because NMN sits at a junction between precursor uptake and NAD+ formation, its cellular concentration is tightly linked to enzyme activity and tissue type. NAD+ participates in redox reactions, signaling, and DNA repair, and its levels decline with age in some animal models, though human evidence remains more limited and context-dependent.
| Property | Value | Notes |
|---|---|---|
| Chemical name | Nicotinamide mononucleotide | Nucleotide derivative of nicotinamide |
| Molecular formula | C11H15N2O8P | Free acid form; salts may differ |
| Molar mass | 334.22 g/mol | Approximate value for free acid |
| CAS Registry Number | 1094-61-7 | Common beta isomer |
| Solubility | Water-soluble | Polar molecule; solubility varies with pH and form |
Dietary sources of NMN include small amounts in certain vegetables, fruits, and other foods, although exact values vary by sample and method. Endogenous NMN concentrations are tightly regulated and often low, making measurement in blood or tissues technically demanding. After oral intake, NMN is thought to be rapidly metabolized in the intestine and liver, and intact NMN may not reach all tissues at high levels. Some rodent studies report increases in tissue NAD+ after oral NMN, while human data remain limited and sometimes rely on blood NAD+ metabolites rather than direct tissue measures.
Research on NMN has focused on aging, metabolic regulation, exercise capacity, and insulin sensitivity, but findings are preliminary. Many human trials are small, short in duration, and use different endpoints, which complicates comparison across studies. No national regulator has approved NMN as a therapeutic drug for any indication. In some countries it is sold as a supplement or research chemical, while other jurisdictions have questioned its status under food or supplement laws. Claims about extending human lifespan or reversing aging are not supported by established clinical evidence.
Research on NMN has expanded because NAD+ concentrations decline with age in some tissues and because NAD+ participates in energy metabolism, DNA repair, and signaling. Animal studies have reported changes in NAD+ levels after NMN administration, but human data are more limited and often focus on safety, pharmacokinetics, and biomarker changes. Questions remain about oral absorption, tissue distribution, and whether changes in blood NAD+ reflect changes inside specific organs. NMN is not an approved drug, and claims about its clinical effects should be distinguished from established biochemical findings.
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide. Its structure combines a nicotinamide ring, a ribose sugar, and a phosphate group. The compound exists in cells as an intermediate in the production of nicotinamide adenine dinucleotide, a central redox cofactor. NMN is distinct from nicotinamide riboside, another related pyridine nucleotide, although the two compounds can converge in metabolic pathways. Its chemical formula is C11H15N2O8P, and it carries a net negative charge at physiological pH.
Color-flow Doppler ultrasound measures the severity of peripheral vascular disease and is used by cardiologists for dynamic evaluation of the heart, heart valves, and major vessels. Stenosis, for example, of the carotid arteries may be a warning sign for an impending stroke. A clot, embedded deep in one of the inner veins of the legs, can be found via ultrasound before it dislodges and travels to the lungs, resulting in a potentially fatal pulmonary embolism. Ultrasound is useful as a guide to performing biopsies to minimize damage to surrounding tissues and in drainages such as thoracentesis. Small, portable ultrasound devices now replace peritoneal lavage in trauma wards by non-invasively assessing for the presence of internal bleeding and any internal organ damage. Extensive internal bleeding or injury to the major organs may require surgery and repair.
== Other research == In October 2021, Relief announced that its collaboration partner, Texas-based Acer Therapeutics, had successfully filed for a New Drug Application with US FDA for their drug ACER-001, for the treatment of Urea Cycle Disorders (UCDs) and Maple syrup urine disease. In September 2021, APR launched a chewable tablet for the treatment of Phenylketonuria, called PKU GOLIKE KRUNCH, in Germany and Italy. APR are also developing Nexodyn, a drug which aids in the management of hard-to-heal ulcers requiring long periods of treatment. Relief is actively developing RLF-100 for non-COVID-19 related acute and chronic lung diseases, such as Pulmonary sarcoidosis.
=== Glycoprotein biotinylation === Glycoproteins can be biotinylated by modifying the carbohydrate residues to aldehydes, which then react with hydrazine- or alkoxyamine-based biotinylation reagents. Sodium periodate oxidizes the sialic acids on glycoproteins to aldehydes to form these stable linkages at pH 4–6. Polyclonal antibodies are heavily glycosylated, and because glycosylation does not interfere with the antibody activity, biotinylating the glycosyl groups is an ideal strategy to generate biotinylated antibodies.
For many years, exobiologists have proposed the existence of a shadow biosphere, a postulated microbial biosphere of Earth that uses radically different biochemical and molecular processes than currently known life. One of the proposals was the existence of lifeforms that use arsenic instead of phosphorus in DNA. A report in 2010 of the possibility in the bacterium GFAJ-1 was announced, though the research was disputed, and evidence suggests the bacterium actively prevents the incorporation of arsenic into the DNA backbone and other biomolecules.
Yellow biotechnology refers to the use of biotechnology in food production (food industry), for example in making wine (winemaking), cheese (cheesemaking), and beer (brewing) by fermentation. It has also been used to refer to biotechnology applied to insects. This includes biotechnology-based approaches for the control of harmful insects, the characterisation and utilisation of active ingredients or genes of insects for research, or application in agriculture and medicine and various other approaches. Gray biotechnology is dedicated to environmental applications, and focused on the maintenance of biodiversity and the remotion of pollutants. Brown biotechnology is related to the management of arid lands and deserts. One application is the creation of enhanced seeds that resist extreme environmental conditions of arid regions, which is related to the innovation, creation of agriculture techniques and management of resources. Violet biotechnology is related to law, ethical and philosophical issues around biotechnology. Microbial biotechnology has been proposed for the rapidly emerging area of biotechnology applications in space and microgravity (space bioeconomy) Dark biotechnology is the color associated with bioterrorism or biological weapons and biowarfare which uses microorganisms, and toxins to cause diseases and death in humans, livestock and crops.
Sources: en.wikipedia.org
== History == In 1832, H.A.L. Wiggers discovered trehalose in an ergot of rye, and in 1859 Marcellin Berthelot isolated it from Trehala manna, a substance made by weevils and named it trehalose. Trehalose has long been known as an autophagy inducer that acts independently of mTOR. In 2017, research was published showing that trehalose induces autophagy by activating TFEB, a protein that acts as a master regulator of the autophagy-lysosome pathway.
== Risk factors == There is limited research on LADA and its etiology. As with both T1D and T2D, the risk of developing LADA depends on both genetic and environmental factors. Genetic risk factors for LADA are similar to T1D, e.g. it is affected by the HLA complex, but also genetic variants associated with T2D have been identified in LADA. LADA has several lifestyle risk factors in common with T2D, such as obesity, physical inactivity, smoking and consumption of sweetened beverages, all of which are linked to insulin resistance. Obesity has been shown to increase the risk of LADA in several studies, and one study showed that the risk was particularly high in combination with having diabetes in the family. Less physical activity increases the risk of developing LADA. A Swedish study showed that low birth weight, in addition to increasing the risk of T2D, increases the risk of LADA. Although smoking has been shown to increase the risk of T2D and coffee consumption to decrease it, the results regarding these products and LADA are unclear. However, results from two studies based on the same population seem to indicate that coffee consumption increases the risk of LADA. Sweetened beverages and processed red meat have been shown to increase the risk of LADA, while consumption of fatty fish has been shown to have a protective effect.
==== Surface roughness ==== The physical topology of a surface will determine the viable environment for bacteria. It may affect a microbe's ability to adhere to its surface. Textile surfaces tend to be very easy for microbes to adhere to due to the abundance of interstitial spacing between fibers.
At that point, the ice is able to safely support the heavier equipment required for that phase, which mostly consists of artificial thickening using a pump or a spraying system. The aim is to bring the thickness up to what is required for the heaviest vehicles that are anticipated when the ice road opens.
Sources: en.wikipedia.org
=== Drawing paste === In the United Kingdom, a medication containing magnesium sulfate, called "drawing paste", is claimed to be useful for small boils or localised infections, and removing splinters. The standard British Pharmacopoeia composition is dried magnesium sulfate 47.76% (by mass), phenol 0.49%, and glycerol to balance.
=== 1989 === January 4: Gulf of Sidra incident between America and Libya, similar to the 1981 Gulf of Sidra incident. January 7: Emperor Hirohito dies, marking the end of the Showa era in Japan. January 11: Communist Hungary introduces political reforms. January 19: The trade union Solidarity is legalized by the Polish government. January 20: George H. W. Bush is inaugurated as 41st President of the United States. February 2: Soviet troops withdraw from Afghanistan. February 3: Alfredo Stroessner was deposed in a coup led by Andrés Rodríguez. February 14: The Contra war effectively ends with the Tesoro Beach Accords happening in El Salvador with Costa Rica, El Salvador, Guatemala, Honduras and Nicaragua participating. An agreement is made that all contra forces are to disband in return for a free election to be held in February 1990. Although a few groups initially reject the agreement they eventually decide to participate. February 15: The Afghan Civil War begins after Soviet troops withdrawing from Afghanistan. February 19–21: Jakarta Informal Meeting II was held in Jakarta. This meeting succeeded in finding two important issues, namely the withdrawal of Vietnamese troops from Cambodia and the prevention of the return of the Pol Pot regime in Cambodia. Later, efforts to resolve the conflict will continue in International Conference in Paris on July 30–31, 1989. March 26: The Soviet Union holds the first round of legislative elections to the Congress of People's Deputies. June 3: Ayatollah Khomeini dies.
=== Carbonate compensation depth === The carbonate compensation depth (CCD) is the point in the ocean where the rate of precipitation of calcium carbonate is balanced by the rate of dissolution due to the conditions present. Deep in the ocean, the temperature drops and pressure increases. Increasing pressure also increases the solubility of calcium carbonate. Calcium carbonate is unusual in that its solubility increases with decreasing temperature. The carbonate compensation depth ranges from 4,000 to 6,000 meters below sea level in modern oceans, and the various polymorphs (calcite, aragonite) have different compensation depths based on their stability.
Internists often can perform and interpret diagnostic tests like EKGs and ultrasound imaging (Point-of-care Ultrasound – PoCUS). Internists who pursue sub-specialties have additional diagnostic tools, including those listed below.
Optical spectrometry, a technique for measuring the distribution of light across the optical spectrum, from the ultraviolet spectral region to the visible and infrared Ion-mobility spectrometry, an analytical technique used to separate and identify ionized molecules in the gas phase based on their ion mobility in a carrier buffer gas Mass spectrometry, an analytical technique that measures the mass-to-charge ratio of charged particles Rutherford backscattering spectrometry, an analytical technique used to determine the structure and composition of materials by measuring the back-scattering of a beam of high energy ions impinging on a sample Neutron triple-axis spectrometry, a technique used in inelastic neutron scattering Gamma-spectrometry, a method used to acquire a quantitative gamma-spectrum measurement Nuclear magnetic resonance spectroscopy, a technique that uses radio frequency pulses and a magnetic field to study the properties of atomic nuclei.
Sources: en.wikipedia.org
NMN is a naturally occurring nucleotide and an intermediate in NAD+ biosynthesis. It consists of nicotinamide attached to a ribose phosphate unit. Cells produce it through the salvage pathway.
NMN is converted to NAD+ by NMNAT enzymes. NAD+ is a coenzyme in redox reactions and a substrate for signaling enzymes. This relationship makes NMN a focus of NAD+ research.
No, NMN and nicotinamide riboside are distinct compounds. Nicotinamide riboside can be phosphorylated to form NMN inside cells. Both are studied as NAD+ precursors.
Nicotinamide mononucleotide is a nucleotide intermediate in the biosynthesis of NAD+. It consists of nicotinamide attached to a ribose phosphate unit. NMN occurs naturally in cells and is present at low levels in some foods.